Dr. Ping Wang 王平
Chief Physician, Associate Professor
Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional treatments for primary and metastatic liver cancer, including mFolfox-based HAIC to downstage inoperable tumors. Management of malignant obstructive jaundice with stenting and HAIC. Radiofrequency ablation for large liver tumors, esophageal stenting, hepatic hemangioma embolization, and HAIC-based targeted immunotherapy.
Dr. Wang holds a PhD in Surgery and a Master’s in Oncology. As a team leader in the Interventional Department and master’s supervisor, Dr. Wang provides clinical care and academic guidance.
Professional roles
- Member, Composite Interventional Group, Interventional Radiology Committee, Chinese Medical Association
- Member, Colorectal Cancer Liver Metastasis Branch, China International Exchange and Promotion Association for Medical and Healthcare
- Member, Interventional Medicine Professional Committee, Chinese Research Hospital Association
- Member, Liver Cancer and Critical Care Professional Committees, China Tumor Minimally Invasive Treatment Alliance
Name order: in Chinese the family name comes first (Wang Ping). Papers usually list the name as Ping Wang or Wang P.
Selected publications
15 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Surg, 2025 (first author): Molecular characterization of breast cancer and multiple primary malignancies: the latest application using unmarked quantitative proteomics. PubMed 40694032
- J Cancer Res Clin Oncol, 2025 (first author): A cross-sectional analysis of the global burden of childhood leukemia from 1990 to 2021. PubMed 41102585
- Acad Radiol, 2025 (first author): Preoperative Prediction of STAS Risk in Primary Lung Adenocarcinoma Using Machine Learning: An Interpretable Model with SHAP Analysis. PubMed 40140276
- J Cancer Res Clin Oncol, 2023 (first author): A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy. PubMed 37247082
- Future Oncol, 2023 (first author): Prediction model based on radiomics and clinical features for preoperative lymphovascular invasion in gastric cancer patients. PubMed 37377070
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion